← Lipoedeem-overzicht

Lipoedeem: referenties en bronnen

De onderstaande bronnen vormen de basis van dit dossier. Ze zijn opgehaald uit PubMed en OpenAlex (2022 tot 2026) en per thema geordend. Achter elke bron staat het bewijsniveau, zodat je in één oogopslag ziet hoe sterk een claim onderbouwd is: systematische review en meta-analyse zijn het sterkst, gevolgd door gerandomiseerde trials, daarna cohort- en cross-sectionele studies, en tot slot narratieve reviews, case reports en opinies.

Overzicht, prevalentie en diagnose

• Cifarelli V. Lipedema: Progress, Challenges, and the Road Ahead. Obesity Reviews, 2025. PMID 40425048. (systematische review)
• Lipedema Diagnosis, Clinical Manifestations, and Therapeutics: A Systematic Review. International Journal of Dermatology, 2026. PMID 41498193. (systematische review)
• Lipedema awareness and knowledge level among medical doctors in Turkey. Phlebology, 2025. PMID 40177931. (cross-sectioneel)
• Abdominal Lipedema: Clinical Diagnosis and Management Through a Proposed Diagnostic Algorithm. Aesthetic Plastic Surgery, 2025. PMID 40938408. (retrospectief)
• Modern approaches to the diagnosis and multimodal management of lipedema. Phlebology, 2026. PMID 42109060. (narratieve review)
• Unraveling lipedema: comprehensive insights and the path to future discoveries. npj Metabolic Health and Disease, 2026. PMID 41548036. (narratieve review)

Oorzaken: genetica en hormonen

• Impact of hormones on lipedema development: a systematic literature review. Archives of Gynecology and Obstetrics, 2026. PMID 41575573. (systematische review)
• The Expression of Adipogenic Marker Is Significantly Increased in Estrogen-Treated Lipedema Adipocytes. Biomedicines, 2024. PMID 38791004. (in-vitro)
• Menopause as a Critical Turning Point in Lipedema. International Journal of Molecular Sciences, 2025. PMID 40806207. (narratieve review)
• AKR1C1 and hormone metabolism in lipedema pathogenesis: a computational biology approach. European Review for Medical and Pharmacological Sciences, 2023. PMID 38112954. (in-silico)
• The Evolutionary Theory of Lipedema. Cureus, 2025. PMID 40861617. (editorial/opinie)
• Lipedema: Insights into Morphology, Pathophysiology, and Challenges. Biomedicines, 2022. PMID 36551837. (narratieve review)

Pathofysiologie

• Current Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis. International Journal of Molecular Sciences, 2022. PMID 35743063. (narratieve review, meest geciteerd)
• Multi-Level Analysis of Adipose Tissue Reveals Increased Endothelial Permeability in Early-Stage Lipedema. Biomedicines, 2022. PMID 35625899. (ex-vivo/in-vitro)
• Metabolic Alterations in Women with Lipedema Compared to Lifestyle-Induced Overweight/Obesity. Biomedicines, 2025. PMID 40299449. (cross-sectioneel)
• Distinct systemic metabolic signatures in premenopausal women with lipedema. Frontiers in Endocrinology, 2026. PMID 42325630. (case-control, metabolomics)
• Lipedema pain, the neglected symptom. Dermatologie, 2023. PMID 37438647. (narratieve review)
• Neuropathic Pain Features in Lipedema Compared to Lymphedema. Lymphatic Research and Biology, 2026. PMID 42253059. (cross-sectioneel)
• Central Sensitization, Pain, and Psychosocial Factors in Individuals with Lipedema. Aesthetic Plastic Surgery, 2026. PMID 42310083. (cross-sectioneel)
• Reduced Serum Endostatin in Premenopausal Women with Lipedema. Diseases, 2026. PMID 42505579. (cross-sectioneel)
• Vascular changes and their implications in lipedema. Frontiers in Cell and Developmental Biology, 2026. PMID 42181679. (narratieve review)
• Lipedema and Dynapenia: Inflammatory Myosteatosis as a Mechanistic Link Between Tissue Expansion and Muscle Dysfunction. International Journal of Molecular Sciences, 2026. PMID 41828544. (hypothese-review)
• The role of extracellular vesicles in adipose tissue dysfunction in lipedema. Frontiers in Cell and Developmental Biology, 2026. PMID 41988381. (hypothese-review)
• Lipedema as a disorder of adipose tissue heterogeneity: insights from single-cell and spatial transcriptomics. Frontiers in Cell and Developmental Biology, 2026. PMID 42388970. (hypothese-review)

Immuun- en microbiële hypotheses

• Is the endotoxin-complement cascade the major driver in lipedema? Trends in Endocrinology and Metabolism, 2024. PMID 38688780. (narratieve review, hypothese)
• Pathophysiology of cellulite: Possible involvement of selective endotoxemia. Obesity Reviews, 2023. PMID 36285892. (narratieve review, analogie)
• The IgG Paradox in Lipedema: More Food Sensitivities, Less Antibody Production. Cureus, 2025. PMID 41185844. (retrospectief cross-sectioneel, n=234)
• Exploring the Immunological Shield Hypothesis. Cureus, 2026. PMID 41909346. (cross-sectioneel, NHANES)
• Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Frontiers in Immunology, 2023. PMID 37575263. (biopt-histologie)
• Defining lipedema’s molecular hallmarks by multi-omics approach. Metabolism, 2025. PMID 40097137. (multi-omics)
• Histological and molecular differences among lipedema, lipohypertrophy and secondary lymphedema. International Journal of Molecular Sciences, 2023. PMID 37108757. (histologisch/moleculair)
• Targeting Mast Cells: Sodium Cromoglycate as a Possible Treatment of Lipedema. La Clinica Terapeutica, 2023. PMID 37994773. (pilot)
• Dietary Inflammatory Index and Mediterranean Diet Score associated with systemic inflammation in women with lipedema. International Journal of Obesity, 2026. PMID 41310256. (cross-sectioneel)
• Inflammatory Markers in Lipedema: NLR, PLR and Mean Platelet Volume. Lymphatic Research and Biology, 2026. PMID 42261591. (case-control)
• Inflammatory Profile of Lipedema: A Comparative Evaluation with Obese and Normal-weight Women. Hormone and Metabolic Research, 2026. PMID 42379186. (retrospectief)

Immuun- en metabole mechanismen (M2-macrofagen, endotoxine, palmitinezuur, gewichtsverlies)

• Lipedema: A Disease Triggered by M2 Polarized Macrophages? Biomedicines, 2025. PMID 40149538. (narratieve review)
• A distinct M2 macrophage infiltrate and transcriptomic profile decisively influence adipocyte differentiation in lipedema. Frontiers in Immunology, 2022. PMID 36605202. (experimenteel, terugpolarisatie in vitro)
• TNF-α in Combination with Palmitate Enhances IL-8 Production via the MyD88-Independent TLR4 Signaling Pathway. International Journal of Molecular Sciences, 2019. PMID 31443599. (celkweek, palmitinezuur-TLR4)
• Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance. JHEP Reports, 2023. PMID 37360906. (celkweek/muismodel, palmitinezuur-TLR4)
• Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid rafts. PLoS One, 2012. PMID 22479476. (celkweek, palmitinezuur-TLR4)
• An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation. Journal of Biological Chemistry, 2018. PMID 29463677. (celkweek, endogene lipogenese)
• Adipose Tissue Biology and Effect of Weight Loss in Women With Lipedema. Diabetes, 2025. PMID 39652636. (gewichtsverlies-effect)
• Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema. Current Developments in Nutrition, 2025. PMID 40125475. (gerandomiseerde trial, secundaire analyse)

Behandeling en leefstijl

• Clinical or cultural? Dietary interventions for lipedema: a systematic review. Maturitas, 2025. PMID 40939491. (systematische review)
• Changes in plasma fatty acid composition following low-carbohydrate vs low-fat diets and pain reduction (Lipodiet). Nutrition Journal, 2026. PMID 41808123. (gerandomiseerde trial)
• Impact of Pycnogenol Use in the Treatment of Patients With Lipedema: A Randomized Controlled Trial. Cureus, 2025. PMID 41393612. (gerandomiseerde trial)
• Clinical effects of TECAR therapy in Stage 2 lipedema: a randomized controlled trial. Turkish Journal of Physical Medicine and Rehabilitation, 2025. PMID 41717523. (gerandomiseerde trial)
• Exercise training in women with lipedema: A systematic review. VASA, 2025. PMID 41243294. (systematische review)
• What is the recommended compression pressure for different clinical indications? Phlebology, 2026. PMID 41432038. (narratieve review)
• Changes During a 7-Month Calorie-Restricted Low-Carbohydrate, High-Fat Dietary Intervention in Women with Lipedema. Nutrients, 2026. PMID 42123982. (prospectief zonder controle)
• Moderate weight loss decreases lipedema-affected body fat mass. JCEM Case Reports, 2026. PMID 41767202. (case report)
• Associations between Dietary Inflammatory Index, ultra-processed food intake, and clinical outcomes in women with lipedema. Frontiers in Nutrition, 2026. PMID 42453672. (cross-sectioneel)
• Effectiveness of diathermy in reducing subcutaneous adipose tissue affected by lipedema: a pilot study. Journal of Bodywork and Movement Therapies, 2026. PMID 42264813. (pilot RCT)
• Dietary supplements for lipedema. Journal of Preventive Medicine and Hygiene, 2022. PMID 36479502. (narratieve review)
• New Perspectives on the Use of Resveratrol in Estrogen-Dependent Conditions. Current Issues in Molecular Biology, 2025. PMID 41020814. (narratieve review)
• Characterization of Gut Microbiota Profile in Lipedema: A Pilot Study. Nutrients, 2025. PMID 41470854. (pilot case-control)
• Lack of Scientific Evidence for the Use of Gestrinone in the Treatment of Lipedema: A Systematic Review. Cureus, 2025. PMID 41426843. (systematische review)
• Targeting Inflammation and Fibrosis in Lipedema: The Potential Role of GLP-1 Receptor Agonist Therapies. Dermatologic Surgery, 2026. PMID 42210892. (narratieve review)

Comorbiditeit en kwaliteit van leven

• Prevalence of comorbidities associated with lipedema. A comparative study with the general population. Phlebology, 2026. PMID 41886595. (cross-sectioneel vergelijkend)
• Health-related quality of life among lipedema patients: A systematic review and meta-analysis. Phlebology, 2026. PMID 41436421. (systematische review en meta-analyse)
• Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology. Journal of Clinical Medicine, 2025. PMID 41156066. (cross-sectioneel observationeel)
• Lipedema in Women and Its Interrelationship with Endometriosis and Other Gynecologic Diseases. Biomedicines, 2026. PMID 41595658. (scoping review)
• Mental and physical health burden and quality of life in Czech women with lipedema. Frontiers in Global Women’s Health, 2025. PMID 40778367. (cross-sectioneel)

Over deze bronnenlijst

Dit dossier is samengesteld uit een gestructureerde literatuurzoektocht en vervolgens onafhankelijk gecontroleerd op wetenschappelijke juistheid en op dekking van elke claim door een bron. Waar een claim alleen op een narratieve review, een case report of een computationele studie berust, is dat in de tekst expliciet aangegeven als hypothese in plaats van als vaststaand feit. Het lipoedeem-veld is jong en verandert snel; deze lijst weerspiegelt de stand van de literatuur begin augustus 2026.